Check out Portal's latest news! For press or media inquiries, please contact info@portal.bio
Sorting
Businesswire • Press Release
Portal Biotechnologies Accelerates Growth with Latest Round Led by NFX, Expanded DARPA Contract, and Broad Adoption Across Top Pharma and Academic Centers
Oversubscribed $9M round to underpin rapid platform expansion across drug discovery, AI data generation, and cell therapy manufacturing Portal surpasses over 100 customers to date, including public highlights by Microsoft, Merck, AbbVie,... Read more
Businesswire • Press Release
Portal Biotechnologies Accelerates Growth with Latest Round Led by NFX, Expanded DARPA Contract, and Broad Adoption Across Top Pharma and Academic Centers
Oversubscribed $9M round to underpin rapid platform expansion across drug discovery, AI data generation, and cell therapy manufacturing Portal surpasses over 100 customers to date, including public highlights by Microsoft, Merck, AbbVie,... Read more
Businesswire • Press Release
Portal Biotechnologies Awarded $8M DARPA Contract to Increase Access to Cell Therapy via a Portable, Red Blood Cell Engineering Device for Rapid Point-of-Care Production and Treatment
Portal’s collaboration with DARPA’s “Red Blood Cell (RBC) Factory” program aims to develop a portable, field-deployable, personalized and scalable cell therapy device that enables diverse cargo delivery to red blood cells within minutes... Read more
Businesswire • Press Release
Portal Biotechnologies Announces Over 50 Partnerships and Oversubscribed $7M Seed Round Led by IA Ventures
Rapid platform adoption with over 50 biopharma and academic partners to date, including 7 of the top 10 pharmaceutical companies Oversubscribed $7M financing proceeds, coupled with revenue, to drive continued growth and launch of next... Read more
Boston Business Journal • Media
Founder of SQZ is back with new startup focused on cell therapies
A year after leaving the company he founded, SQZ Biotechnologies, Armon Sharei has a new venture that has a similar approach to getting stuff inside cells. Read more
Boston Business Journal • Media
SQZ founder's new startup goes from zero to $1M in revenue in a year
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Portal Biotechnologies, Inc., a cell engineering platform company, announced its emergence from stealth today. Established in 2023, Portal is implementing a simplified approach to intracellular delivery,... Read more
Portal accelerates growth with latest $9M round led by NFX, an expanded DARPA contract, and broad adoption!
1 of 2